7-(hydroxymethyl)-12-methylbenz(a)anthracene sulfate ester: carcinogenic major metabolite of 7,12-dimethylbenz(a)anthracene; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 23688094 |
MeSH ID | M0104439 |
Synonym |
---|
7-hydroxymethyl-12-methylbenz(a)anthracene sulfate sodium |
12-methylbenz(a)anthracene-7-methanol sulfate sodium |
7-hydroxymethyl-12-methylbenz(a)anthracene sulfate ester |
7-(hydroxymethyl)-12-methylbenz(a)anthracene sulfate ester |
benz(a)anthracene-7-methanol, 12-methyl-, hydrogen sulfate |
7-sulfooxymethyl-12-methylbenz(a)anthracene sodium salt |
benz(a)anthracene-7-methanol, 12-methyl-, sulfate (ester), sodium salt |
ccris 4240 |
sodium 7-sulfooxymethyl-12-methylbenz(a)anthracene |
110933-34-1 |
80733-96-6 |
7-sulfooxymethyl-12-methylbenz(a)anthracene |
DTXSID80911903 |
sodium (12-methyltetraphen-7-yl)methyl sulfate |
sodium 7-sulfooxymethyl-12-methylbenz[a]anthracene |
sodium;(12-methylbenzo[a]anthracen-7-yl)methyl sulfate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.96) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |